Whitsell Innovations, Inc. presenting at the Medical Affairs and Scientific Communications 2016 Annual Forum

Whitsell Innovations, Inc. presenting at the Medical Affairs and Scientific Communications 2016 Annual Forum

Robin Whitsell, Founder and President of Whitsell Innovations (WI), Inc., and Ann Winter-Vann, PhD, Clinical Writing Lead, will present at the Medical Affairs and Scientific Communications 2016 Annual Forum March 21 through March 23, 2016 in Kissimmee, Florida. This cross-functional forum is sponsored by the Drug Information Association (DIA) and spotlights topics related to medical communication, medical science liaison, medical call center, and medical writing.
Ms. Whitsell’s presentations are entitled “Lies, Damn Lies, and Statistics: Keeping Publications Honest” (Session 3 Track E) and Saying the Unsaid: Sponsor and Vendor Relationships and Negotiations – “The Vendor Side” (Session 6 Track D).

Ms. Whitsell’s presentations are entitled “Lies, Damn Lies, and Statistics: Keeping Publications Honest” (Session 3 Track E) and Saying the Unsaid: Sponsor and Vendor Relationships and Negotiations – “The Vendor Side” (Session 6 Track D).

[quotes class=”quoteleft”]“I’m excited to attend and present at this meeting where so many life science professionals are sharing their expertise,” says Ms. Whitsell. “This is the fourth year in a row that Dr. Winter-Vann and I have had the opportunity to attend and present on behalf of WI; each year, we have seen how this meeting has achieved that goal. It’s an honor to interact and present with thought leaders in medical communications.”[/quotes]

[quotes class=”quoteleft”]”I am honored to have the opportunity to present at DIA’s Medical Affairs and Scientific Communications conference again this year,” says Dr. Winter-Vann. “The program continues to be excellent, and I am thrilled to be included among such distinguished colleagues.”[/quotes]

Dr. Winter-Vann’s presentation is entitled “Best Practices for Writing Clinical Study Reports for Disclosure” (Session 3 Track D) and “Drafting Regulatory Documents to Minimize Quality Review Findings” (Session 4 Track D).

ABOUT DRUG INFORMATION ASSOCIATION
DIA is a nonprofit, global, professional association of nearly 18,000 members who work in every facet of the discovery, development, and life cycle management of pharmaceuticals, medical devices, and related products. DIA is committed to the broad dissemination of information among its members, with continuously improved professional practice as the goal. DIA serves its members in a neutral, global environment that operates independent of the influence of any one organization or authority.
Website: www.diaglobal.org

ABOUT WHITSELL INNOVATIONS, INC.
WI is a Women’s Business Enterprise National Council (WBENC) certified woman owned full-service medical and scientific writing company headquartered in Chapel Hill, North Carolina.
Contact: info@whitsellinnovations.com
Website: www.whitsellinnovations.com
This release contains certain forward-looking statements which involve known and unknown risks, delays, uncertainties and other factors not under the company’s control. Whitsell Innovations, Inc.’s actual results, performance, or achievements could be materially different from those projected by these forward-looking statements. Given these risks and uncertainties, you are cautioned not to place undue reliance on the forward-looking statements.